Matrix metalloproteinases expressed in squamous cell carcinoma of the oral cavity: Correlation with clinicopathologic features and neo-adjuvant chemotherapy response

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 3, 1999, Pages 279-284

  Arenas Huertero, F J ^a   Herrera Goepfert, R ^a   Delgado Chavez, R ^a   Zinser Sierra, J W ^a   De La Garza Salazar, J G ^a   Herrera Gomez, A ^b   Perez Cardenas, E ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b Instituto Nacional de Cancerologia ^*

Author keywords

Chemotherapy; Extracellular matrix; Gelatinases; Head and neck cancer; Oral cavity; Squamous cell carcinoma

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER CELL CULTURE; ENZYME RELEASE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MOUTH NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM PROTEINS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032737415     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vockes E., Weichselbaum R., Lippman S., Ki Hong W.: Head and neck cancer. N. Eng. J. Med. 328: 184-194.1993.
2. Parkin D. M., Laara E., Muir C.: Estimates of the worldwide frequency of sixteen major cancer in 1980. Int. J. Cancer. 41: 184-197. 1988.
3. Decker J., Goldstein J.: Risk factors in head and neck cancer. N. Eng. J. Med. 306: 1151-1155. 1982.
4. Muller D., Breathnach R., Engelmann A., et. al.: Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumors. Cancer Res. 48: 550-556. 1991.
5. Stetler-Stevenson W. G., Aznavoorian S., Liotta L. A.: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9: 541-572. 1993.
6. Pepper M. S., Montesano R.: Proteolytic balance and capillary morphogenesis. Cell Differ. Dev. 32: 319-328. 1990.
7. Folkman J.: What is the evidence that tumors are angiogenesis dependent?. J. Natl. Cancer Inst. 82: 4-6. 1990.
8. Stetler-Stevenson W. G., Liotta L .A., Kleiner D. E.: Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7: 1434-1441. 1993.
9. Woessner J. F.: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2154. 1991.
10. Muller D., Breathnach R., Engelmann A., et al.: Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumors. Int. J. Cancer. 48: 550-556. 1991.
11. Polette M., Clavel C., Muller D., Abecassis J., Binninger I., Birembaut P.: Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization. Invasion Metastasis. 11: 76-83. 1991.
12. Berthois Y., Katzenellenbogen J. A., Katzenellenbogen B. S.: Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. ScI. U.S.A. 83: 2496-2500. 1986.
13. Bradford M. M.:A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254. 1976.
14. Marbaix E., Donnez J., Courtoy P. J., Eeckout Y.: Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc. Natl. Acad. Sci. U.S.A. 89:11789-11793. 1992.
15. Kusukawa J., Sasaguri Y., Shima I., Kameyama T., Morimatsu M.: Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathological study. Am. J. Clin. Pathol. 99: 18-23. 1993.
16. Liotta L. A., Rao C. N., Barsky S. H.: Tumor invasion and the extracellular matrix. Lab. Invest. 49: 636-649. 1983.
17. Yamagata S., Ito Y., Tanaka R., Shimizu S.: Gelatinases of metastatic cell lines of murine colonie carcinoma as detected substrate-gel electrophoresis. Biochem. Biophys. Res. Comm. 151: 158-162. 1988.
18. Schantz S. P.: Head and neck oncology research. Curr. Op. Oncol. 6: 265-271. 1994.
19. Van der Stappen W. J., Hendriks T., Wobbes T.: Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int. J. Cancer. 45: 1071-1078. 1990.
20. Bellon G., Caulet T., Cam Y., et al.: Immunohistochemical localization of macromolecules of the basement membrane and extracellular matrix of human gliomas and meningiomas. Acta Neuropathol. 66: 245-249. 1985.
21. Kubbota T., Nakagawa T., Hosotani K. et al.: Immunohistochemical study of extracellular matrix in schwanomas: in vivo and in vitro observations. Brain Tumor Pathol. 9: 23-28. 1992.
22. Juarez J., Clayman G., Nakajima M.: Role and regulation of expression of 92 KDa type-IV collagenase (MMP-2) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int. J. Cancer. 55: 10-18. 1993.
23. Sawaya R., Tofilon P. J, Mohanam S., et al.: Induction of tissue-type plasminogen activator and 72-KDa, Type-IV collagenase by ionizing radiation in rat astrocytes. Int. J. Cancer. 56: 214-218. 1994.
24. Garbisa S., Scagliotti G., Masiero L., et al.: Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res. 52: 4548-4549. 1992.
25. Davis G. E.: Identification of abundant latent 94 KDa gelatin-degrading metalloprotease in human saliva which is activated by acid exposure: implications for a role in digestion of collagenous proteins. Arch. Biochem. Biophys. 286: 551. 1991.